Nektar Therapeutics
- Pharmaceutical Preparations
- San Francisco, California
Compensation history
Top executives at Nektar Therapeutics received an average of $4M per person in annual compensation from 2006 to 2021.
By year
- 2021
HR$11MHoward W. RobinPresident and Chief Executive OfficerGL$5MGil M. LabrucherieChief Operating Officer and Chief Financial OfficerJZ$5MJonathan ZalevskySenior Vice President and Chief Research and Development OfficerJN$4MJohn NorthcottSenior Vice President and Chief Commercial OfficerMW$4MMark A. WilsonSenior Vice President and General Counsel- 2020
HR$11MHoward W. RobinPresident and Chief Executive OfficerGL$5MGil M. LabrucherieChief Operating Officer and Chief Financial OfficerJZ$5MJonathan ZalevskyChief Research and Development OfficerJN$4MJohn NorthcottSenior Vice President and Chief Commercial OfficerMW$3MMark A. WilsonSenior Vice President and General Counsel
Executives
We found 21 executives who work or worked at Nektar Therapeutics.
Howard Robin
Nektar Therapeutics
Chief Executive Officer
Gil Labrucherie
Nektar Therapeutics
Chief Financial Officer
John Northcott
Nektar Therapeutics
Senior Vice President and Chief Commercial Officer
Mark Wilson
Nektar Therapeutics
General Counsel
Jonathan Zalevsky
Nektar Therapeutics
Senior Vice President and Chief Research and Development Officer
Stephen Doberstein
Nektar Therapeutics
Chief Research and Development Officer
Maninder Hora
Nektar Therapeutics
Senior Vice President Pharmaceutical Development and Chief Technical Operations Officer
Jillian Thomsen
Nektar Therapeutics
Chief Accounting Officer
News
About Nektar Therapeutics
- Industry classifications
- Manufacturing
- Chemicals And Allied Products
- Drugs
- Pharmaceutical Preparations
- 455 Mission Bay Boulevard South, San Francisco, California 94158
- 4154825300
- December 31
- Former names
- INHALE THERAPEUTIC SYSTEMS INC
- INHALE THERAPEUTIC SYSTEMS